12ᵗʰ International Symposium on Hodgkin Lymphoma
back to
back to
Program
Schedule
22.10.2022
23.10.2022
24.10.2022
Scientific Committee
Media
Photos
Videos
Downloads
Abstracts
Newsletters
Acknowledgements
Sponsors
Other Archives
ISHL12
Update on Hodgkin Lymphoma
ISHL11
ISHL10
ISHL9
ISHL8
ISHL7
Back to video list
Why I recommend PET-guided ABVD
Speaker
Alexander Fosså
Session
Advanced Stages
Others Talks of this Session
Why I recommend BV-AVD
Why I recommend PET-adapted escalated BEACOPP
Discussion forum: Challenging standard recommendations from a patient's, nurse's and physician's perspective
WS Report: Learning through International Collaboration
FDG-PET and serum TARC levels after one cycle of BV-AVD in advanced stage Hodgkin lymphoma patients: results from the very early PET-response adapted EORTC-COBRA trial
Treatment related morbidity in patients with classical Hodgkin Lymphoma: results of the ongoing, randomized phase III HD21 Trial by The German Hodgkin Study Group
This website uses cookies to ensure you get the best experience on our website. By using our site you agree to our use of cookies.
Learn more
Got it!